Soleno Therapeutics, Inc. (SLNO) 当前追踪市盈率 (P/E) 为 133.8, 前瞻市盈率为 13.3. 追踪盈利收益率为 0.75%, 前瞻盈利收益率 7.51%. PEG 0.01 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $8.65.
本页证实的标准:
SharesGrow 综合评分： 51/100 其中 1/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -5.2 | 0.10 | 18.28 | 43.29 | - |
| 2017 | -5.2 | 0.09 | 3.05 | -0.05 | - |
| 2018 | -13.4 | 0.21 | 5.90 | 0.00 | - |
| 2019 | -16.3 | -0.25 | 33.58 | 0.00 | - |
| 2020 | -24.5 | 0.32 | 13.27 | 0.00 | - |
| 2021 | -5.3 | -0.09 | 9.19 | 0.00 | - |
| 2022 | -3.5 | 0.07 | 8.03 | 0.00 | - |
| 2023 | -17.0 | 0.96 | 4.21 | 0.00 | - |
| 2024 | -10.3 | -0.12 | 7.37 | 0.00 | - |
| 2025 | 117.9 | -1.08 | 5.47 | 12.93 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $-58.35 | $1.45M | $-12.07M | -831.6% |
| 2017 | $-26.18 | $-1.55B | $-15.67M | - |
| 2018 | $-9.54 | $0.00 | $-13.34M | - |
| 2019 | $-15.78 | $0.00 | $-35.92M | - |
| 2020 | $-3.68 | $0.00 | $-15.38M | - |
| 2021 | $-5.56 | $0.00 | $-29.56M | - |
| 2022 | $-2.42 | $0.00 | $-20.32M | - |
| 2023 | $-2.36 | $0.00 | $-38.99M | - |
| 2024 | $-4.38 | $0.00 | $-175.85M | - |
| 2025 | $0.39 | $190.41M | $20.89M | 11% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $3.89 | $3.33 – $4.89 | $472.71M | $453.92M – $498.82M | 11 |
| 2027 | $6.56 | $4.00 – $8.28 | $721.63M | $676.19M – $801.61M | 9 |
| 2028 | $9.18 | $4.72 – $13.23 | $1B | $1B – $1B | 7 |
| 2029 | $12.81 | $11.43 – $15.01 | $1.35B | $1.24B – $1.53B | 2 |
| 2030 | $16.04 | $14.31 – $18.79 | $1.64B | $1.5B – $1.85B | 5 |
